Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Infrastructure Partners (GIP) is a leading independent infrastructure fund manager that specializes in equity and debt investments in high-quality infrastructure assets. The firm focuses on the energy, transport, digital, and water/waste sectors, managing a portfolio that includes major international airports, shipping ports, and renewable energy platforms. In October 2024, GIP was acquired by BlackRock for approximately $12.5 billion, creating a premier global infrastructure investment platform with over $170 billion in multi-asset class infrastructure AUM. Headquartered in New York, GIP is recognized for its operational approach to infrastructure investing, aiming to improve the performance and value of its portfolio companies. While the firm does not focus on therapeutic drug development, its investments provide the essential physical framework for global commerce and utility services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Infrastructure Partners.